about
Echocardiographic assessment after surgical repair of tetralogy of fallotTreatment of right ventricular outflow tract dysfunction: a multimodality approach.International cooperation in healthcare: model of IRCCS Policlinico San Donato and Bambini Cardiopatici nel Mondo Association for congenital heart diseases.The care for adults with congenital heart disease: organization and function of a grown-up congenital heart disease unit.SNPs and real-time quantitative PCR method for constitutional allelic copy number determination, the VPREB1 marker case.Serum NT-proBNP Levels Are Not Related to Vitamin D Status in Young Patients with Congenital Heart DefectsEffect of bosentan on exercise capacity and clinical worsening in patients with dual down and eisenmenger syndrome.Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence.Timing of pulmonary valve replacement after tetralogy of Fallot repair.Role of imaging in interventions on structural heart disease.Evaluation of right ventricular function in adults with congenital heart defects.Closure of patent foramen ovale defects using GORE® CARDIOFORM septal occluder.Surgical rescue after transcatheter interventional procedures in congenital heart disease patients: an existing problem.Aortic coarctation complicated by wall aneurysm: the role of covered stents.Neoaortic valve and root complex evolution after Ross operation in infants, children, and adolescents.Transcatheter PFO closure with GORE(®) septal occluder: early and mid-term clinical results.Melody transcatheter pulmonary valve implantation. Results from the registry of the Italian Society of Pediatric Cardiology.Patient-specific simulations for planning treatment in congenital heart disease.Blood-threshold CMR volume analysis of functional univentricular heart.Percutaneous treatment of aortic isthmus atresia: use of radiofrequency perforation and covered stents.The impact of actual and perceived disease severity on pre-operative psychological well-being and illness behaviour in adult congenital heart disease patients.Percutaneous Pulmonary Valve Implantation Contraindicated by Severe Aortic Regurgitation Due to Left Coronary Sinus Deformation.Heart failure in grown-up congenital heart disease.Surgical mitral valve replacement with the Melody valve in infants and children: the Italian experience.Cardiac magnetic resonance: impact on diagnosis and management of patients with congenital cardiovascular disease.Coronary-cameral fistulas: indications and methods for closure.Goose-neck snare-assisted transcatheter ASD closure: A safety procedure for large and complex ASDs.Hemodynamic, not ventilatory, inefficiency is associated with high VE/VCO2 slope in repaired, noncyanotic congenital heart disease.Residual shunting after percutaneous PFO closure: how to manage and how to close.Novel percutaneous suture-mediated patent foramen ovale closure technique. Early results of the NobleStitch EL Italian Registry.First Surgical Melody Valve-In-Valve Implantation for Early Degeneration in Mitral Position.Stenting complex aortic coarctation: simulation in a 3D printed model.Segmentation of cardiac magnetic resonance cine images of single ventricle: including or excluding the accessorial ventricle?Multi-modal imaging support in a staging percutaneous pulmonary valve implantation.The Edwards Valeo lifestents in the treatment and palliation of congenital heart disease in infants and small children.Four-year cardiac magnetic resonance (CMR) follow-up of patients treated with percutaneous pulmonary valve stent implantation.Percutaneous management of failed bioprosthetic pulmonary valves in patients with congenital heart defects.Cardiac magnetic resonance before and after percutaneous pulmonary valve implantation.Prediction of stenting related adverse events through patient-specific finite element modellingThe use of covered stents in the field of interventional procedures for congenital heart defects
P50
Q27008403-EB2274B4-7CCD-4F3D-AD96-E25B49368C2DQ30355933-81FD384A-E092-4258-990E-2329401BE3C4Q33646843-0FB207E5-076F-487C-9915-84DF2F68B808Q33646848-64DF7C2E-3E43-4064-9E4A-223BD77C0766Q33890605-FB9EADBB-469C-4D9B-A6FF-D67CC21C3FFAQ36587094-D8132626-9F4D-47F4-8FC6-570A910D3A61Q36611236-889810C4-5860-4C09-8F5B-5D390E6FF3D9Q37897756-94292D1B-3FDB-4CB0-A563-7FAE27F1E754Q38036336-ED466546-9EEB-4A50-A9AA-BD436BD7A4B7Q38161523-03C43DEB-7E0D-4D28-9D13-6677412611A6Q38197300-D2E697D1-1818-404D-ACC4-36BA5CDFF22FQ38906437-3FE1E82E-2215-4BB1-828F-3D23F565648FQ38989030-C919CA66-77E8-41DA-832B-CB7BF77F897EQ39280306-F0237699-787A-4F35-BDEF-B1E32911F958Q43577623-63A63C86-371C-409B-9ADF-1D2639DAC688Q44255954-E2522F72-04CE-43A3-9069-85B3697EA4EAQ44274052-EAB67FAF-8B88-4868-AB0E-576A7AE2BCBEQ47213357-C47CBD1B-9934-452B-9F41-11286324B576Q47557987-097742F6-5DB0-4B4F-AE45-5AC9460DEA18Q48242701-134C5FDA-6864-4FEC-8B8C-A6455EE010D2Q48271109-ADC1428E-3BC7-481D-BD0B-0A5A3204D852Q49832177-33EA1343-E52B-4B29-ABDB-C4D276D633DFQ50070703-700B6DA3-F031-4AC4-8D93-D00220CA1C15Q50976546-4F0F7BF2-3172-4927-8798-E58B84CCA5D9Q51033788-413A46CA-A6AB-4BFD-8E5B-FFF45BD19FBFQ51333938-2388532F-A3A8-4916-9B76-45A5457995F6Q51565451-42B26C80-A061-4C43-8C28-24A5187C1059Q51632042-1513E403-44ED-4F34-8047-9BC55CB7C850Q51801626-8A036BAC-1B5E-4075-8BD9-C4B78F756474Q52608057-522C946F-0484-4FF8-B28D-EAD17BA205CDQ52640020-393DEE58-A39A-4AF5-AB3D-F38A4FAE5C77Q52730036-85C4BCFF-0CC5-433D-8D89-F6AD0C7D0D3CQ53143428-CDB3CE59-5FD4-4498-AB8B-6057651F4244Q53213306-58018A50-1F91-4D6E-B8D7-61484CB4A061Q53322882-E59278C5-EF7B-41FA-85AF-1C10D126E203Q53499283-8C02C924-D8D1-4105-B092-9106FB71A6ADQ53554214-D561EE0E-30C9-4A49-AE3E-8C612D57ECE4Q53659766-B2386537-121B-49A0-B331-116226561A04Q56981619-1B0E242C-6664-40F1-A28C-FEC732E2E92AQ57279352-C1A75CC4-BB44-44B3-B590-C21CAC2EB7E2
P50
description
researcher (ORCID 0000-0001-9734-3007)
@en
wetenschapper
@nl
name
M Carminati
@en
M Carminati
@nl
type
label
M Carminati
@en
M Carminati
@nl
prefLabel
M Carminati
@en
M Carminati
@nl
P31
P496
0000-0001-9734-3007